Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The oncostatin M signalling pathway: reversing the neoplastic phenotype?

Molecular medicine today - 1 Sept 1999

Grant S L, Begley C G

Abstract excerpt

Oncostatin M (OSM) is a member of the interleukin 6 (IL-6) family of cytokines and was originally identified by its ability to inhibit proliferation of melanoma cells but augment the growth of normal fibroblasts. OSM has pleiotropic effects on many different cell types, but here we focus on its ability to inhibit the proliferation of cell lines derived from several tumour types, including breast carcinoma,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Phenotype
Share to Antineoplastic Agents
Share to OSM gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Peptides

Share to Signal Transduction

Source

Identifiers

PMID: 10462753
DOI: 10.1016/s1357-4310(99)01540-3

Genes

OSM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The oncostatin M signalling pathway: reversing the neoplastic phenotype?PMID 10462753Read ↗

Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.Semantic proximity Read ↗

Complete inhibition of in vivo glioma growth by oncostatin MSemantic proximity Read ↗

Stromal Oncostatin M axis promotes breast cancer progressionSemantic proximity Read ↗

Oncostatin M cytokine promotes breast cancer progression by remodelling the extracellular matrix and activating integrin signalling in cancer cellsSemantic proximity Read ↗

Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.Semantic proximity Read ↗

STAT3-mediated SMAD3 activation underlies Oncostatin M-induced SenescenceSemantic proximity Read ↗

Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.Semantic proximity Read ↗

Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transitionSemantic proximity Read ↗

Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells.Semantic proximity Read ↗

Cloning and characterization of human oncostatin M promoterSemantic proximity Read ↗

Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro‐angiogenic phenotype and increased cell motility and invasivenessSemantic proximity Read ↗

Oncostatin M receptor overexpression promotes tumour progression in squamous cell carcinoma, via hypoxia signalling and multiple effects on the tumour microenvironmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.